Skip to main content

Don’t drop your diet yet, but scientists have discovered how CRISPR can burn fat

 

A personalized therapy for metabolic conditions that are linked to obesity could involve removing a small amount of a person’s fat, transforming it into an energy-burning variation using CRISPR gene-editing, and then re-implanting it into the body, according to researchers from the University of Massachusetts Medical School.

Recommended Videos

In tests involving mice, the implanted human fat cells helped lower sugar concentrations in the blood and decrease fat in the liver. When the mice were put on a high-fat diet, the ones that had been implanted with the human beige fat only gained half as much weight as those that had been implanted with regular human fat.

“Over the last decade, it has become clear that humans have ‘white’ adipose tissue that stores fat, but also a less abundant type of adipose tissue called ‘beige” or ‘brown,’ that can burn fat,” Michael Czech, a professor in molecular medicine at the University of Massachusetts Medical School, told Digital Trends. “Beige adipose tissue also secretes factors that are beneficial to the liver and muscles and can combat obesity-related Type 2 diabetes. These findings have led to the concept that enhancing the amount of brown adipose tissue in people may enhance their health and help to prevent diabetes.”

Czech said that the researchers’ work is exciting for a couple of reasons. The first is that the team has uncovered the specific gene, Nrip1, that prevents both human and mouse adipocytes from expressing these “beige” characteristics. The second is that, having discovered it, they’ve also found a way to delete it using CRISPR technology. Once the gene has been eliminated, white fat cells are converted into more “beige-like,” fat-burning condition.

It’s still early days for the project, but the research thus far is certainly promising. “Just like CAR-T technology in the cancer field, where blood cells from a patient can be expanded and modified genetically to fight tumors when injected back into the same patient, we envision using fat progenitor cells from patients with metabolic disorders … to alleviate disease,” Silvia Corvera, another leading professor in molecular medicine at the University of Massachusetts Medical School, who worked on the project, told Digital Trends.

A paper describing the work, titled “CRISPR-enhanced human adipocyte ‘browning’ as cell therapy for metabolic disease,” is available to read online.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Google just gave vision to AI, but it’s still not available for everyone
Gemini Live App on the Galaxy S25 Ultra broadcast to a TV showing the Gemini app with the camera feature open

Google has just officially announced the roll out of a powerful Gemini AI feature that means the intelligence can now see.

This started in March as Google began to show off Gemini Live, but it's now become more widely available.

Read more
This modular Pebble and Apple Watch underdog just smashed funding goals
UNA Watch

Both the Pebble Watch and Apple Watch are due some fierce competition as a new modular brand, UNA, is gaining some serous backing and excitement.

The UNA Watch is the creation of a Scottish company that wants to give everyone modular control of smartwatch upgrades and repairs.

Read more
Tesla, Warner Bros. dodge some claims in ‘Blade Runner 2049’ lawsuit, copyright battle continues
Tesla Cybercab at night

Tesla and Warner Bros. scored a partial legal victory as a federal judge dismissed several claims in a lawsuit filed by Alcon Entertainment, a production company behind the 2017 sci-fi movie Blade Runner 2049, Reuters reports.
The lawsuit accused the two companies of using imagery from the film to promote Tesla’s autonomous Cybercab vehicle at an event hosted by Tesla CEO Elon Musk at Warner Bros. Discovery (WBD) Studios in Hollywood in October of last year.
U.S. District Judge George Wu indicated he was inclined to dismiss Alcon’s allegations that Tesla and Warner Bros. violated trademark law, according to Reuters. Specifically, the judge said Musk only referenced the original Blade Runner movie at the event, and noted that Tesla and Alcon are not competitors.
"Tesla and Musk are looking to sell cars," Reuters quoted Wu as saying. "Plaintiff is plainly not in that line of business."
Wu also dismissed most of Alcon's claims against Warner Bros., the distributor of the Blade Runner franchise.
However, the judge allowed Alcon to continue its copyright infringement claims against Tesla for its alleged use of AI-generated images mimicking scenes from Blade Runner 2049 without permission.
Alcan says that just hours before the Cybercab event, it had turned down a request from Tesla and WBD to use “an icononic still image” from the movie.
In the lawsuit, Alcon explained its decision by saying that “any prudent brand considering any Tesla partnership has to take Musk’s massively amplified, highly politicized, capricious and arbitrary behavior, which sometimes veers into hate speech, into account.”
Alcon further said it did not want Blade Runner 2049 “to be affiliated with Musk, Tesla, or any Musk company, for all of these reasons.”
But according to Alcon, Tesla went ahead with feeding images from Blade Runner 2049 into an AI image generator to yield a still image that appeared on screen for 10 seconds during the Cybercab event. With the image featured in the background, Musk directly referenced Blade Runner.
Alcon also said that Musk’s reference to Blade Runner 2049 was not a coincidence as the movie features a “strikingly designed, artificially intelligent, fully autonomous car.”

Read more